Rebus Holdings, Inc. (RBSH)

OTCMKTS: RBSH · Delayed Price · USD
0.0120
0.0000 (0.00%)
May 23, 2022 12:00 AM EDT - Market closed
Market Cap385,594
Revenue (ttm)n/a
Net Income (ttm)2.09M
Shares Out32.13M
EPS (ttm)0.68
PE Ratio0.02
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Open0.0000
Previous Close0.0120
Day's Range0.0000 - 0.0000
52-Week Range0.0070 - 0.1200
Beta-14.08
AnalystsBuy
Price Targetn/a
Earnings Daten/a

About RBSH

Rebus Holdings, Inc. focuses on the research and development of precision therapeutics for the treatment of cancer. Its lead asset is RT-AR001, an adenosine receptor antagonist for tumor infiltration and enhanced outcomes when administered intra-tumorally. The company was founded in 2003 and is based in Westlake Village, California.

IndustryBiotechnology
Founded2003
Employees1
Stock ExchangeOTCMKTS
Ticker SymbolRBSH
Full Company Profile

News

Inspyr Therapeutics Secures $500,000 to Support the Development of its Adenosine Pipeline

Proceeds support the development of lead asset, RT-AR001, an adenosine receptor antagonist Funds were secured from an existing institutional investor WESTLAKE VILLAGE, CA / ACCESSWIRE / January 12, 2021...

1 year ago - Accesswire